BELLICUM PHARMACEUTICALS INC's ticker is and the CUSIP is 079481404. A total of 29 filers reported holding BELLICUM PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $352 | -54.2% | 1,066 | 0.0% | 0.00% | – |
| Q4 2022 | $768 | -23.2% | 1,066 | 0.0% | 0.00% | – |
| Q3 2022 | $1,000 | 0.0% | 1,066 | 0.0% | 0.00% | – |
| Q2 2022 | $1,000 | -50.0% | 1,066 | 0.0% | 0.00% | – |
| Q1 2022 | $2,000 | 0.0% | 1,066 | -28.3% | 0.00% | – |
| Q4 2021 | $2,000 | -50.0% | 1,487 | 0.0% | 0.00% | – |
| Q3 2021 | $4,000 | -20.0% | 1,487 | 0.0% | 0.00% | – |
| Q2 2021 | $5,000 | -16.7% | 1,487 | 0.0% | 0.00% | – |
| Q1 2021 | $6,000 | +20.0% | 1,487 | 0.0% | 0.00% | – |
| Q4 2020 | $5,000 | -50.0% | 1,487 | 0.0% | 0.00% | – |
| Q3 2020 | $10,000 | -9.1% | 1,487 | -3.3% | 0.00% | – |
| Q2 2020 | $11,000 | – | 1,538 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ikarian Capital, LLC | 448,101 | $537,000 | 0.11% |
| Long Focus Capital Management, LLC | 327,692 | $393,000 | 0.04% |
| Boxer Capital, LLC | 56,950 | $68,000 | 0.00% |
| SHUFRO ROSE & CO LLC | 12,941 | $16,000 | 0.00% |
| Baker Brothers Advisors | 249,123 | $299,000 | 0.00% |
| BOOTHBAY FUND MANAGEMENT, LLC | 45,057 | $54,000 | 0.00% |
| Orion Capital Management LLC | 500 | $1,000 | 0.00% |
| Parallel Advisors, LLC | 10 | $0 | 0.00% |
| WELLS FARGO & COMPANY/MN | 779 | $1,000 | 0.00% |
| NORTHERN TRUST CORP | 10,981 | $13,000 | 0.00% |